Pharmacist-led continuous glucose monitoring for people with prediabetes
Official title: Redefining Prediabetes Care: Pharmacist-Led Continuous Glucose Monitoring to Drive Lifestyle Change
Run by University of South Florida · NCT07529366 · Data updated 2026-11-12
Pharmacists will try continuous glucose monitoring to see if it improves blood sugar and health habits in adults with prediabetes.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | University of South Florida Academic / other |
| Locations | 2 sites (Tampa, Florida and 1 other locations) |
| Status | Recruiting |
| Started | October 6, 2026 |
| Main results expected | July 31, 2027 |
| Study ends | July 31, 2027 |
| Registry record updated | October 7, 2026 |
| Trial ID | NCT07529366 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–70 with prediabetes (HbA1c 5.7–6.4%), who have not used CGM in the prior 6 months and have a smartphone compatible with the Dexcom Stelo system, are the intended participants.
✕Probably not a fit
People with diagnosed diabetes, recent problematic hypoglycemia, pregnancy, planned dialysis, or no compatible smartphone are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational program uses pharmacist-led wearable continuous glucose monitoring (Dexcom Stelo) in adults with prediabetes and compares outcomes to a historical cohort without CGM. The primary metabolic endpoint is change in hemoglobin A1c at 12 weeks, and investigators will also compare CGM-derived glycemic metrics from baseline to the end of the wear period in the intervention group. Health behavior and quality-of-life changes will be measured with the Summary of Diabetes Self-Care Activities (SDSCA) and the SF-36 at baseline, week 4, and study end. Participants must be 18–70 years old, have prediabetes-range A1c, and a smartphone compatible with the Dexcom Stelo system.
Why it matters
Potential benefit: If successful, the program could help people with prediabetes lower average glucose levels and adopt healthier self-care behaviors earlier.
How similar studies have gone: Previous CGM studies in people with diabetes and at-risk adults have shown behavior change and improved glycemic metrics, but pharmacist-led CGM specifically in prediabetes remains relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * adults 18-70 years of age * prediabetes (HbA1c 5.7-6.4%) * compatible smartphone with the Dexcom Stelo sensor system * have not have worn a CGM in the last 6 months prior to enrollment Exclusion Criteria: * any of the following forms of diabetes: type 1 diabetes, type 2 diabetes, monogenic diabetes, cystic fibrosis-related diabetes, post- transplant diabetes, latent autoimmune diabetes * problematic hypoglycemia in the prior 6 months \[defined as recurrent (more than one) level 2 hypoglycemic events (glucose \<54mg/dL ) that persist despite multiple attempts to adjust medication(s) and/or modify the diabetes/treatment plan or a history of one level 3 hypoglycemic event (glucose \<54mg/dL) characterized by altered mental and/or physical state requiring third-party assistance for treatment of hypoglycemia\] * pregnant, or planning to become pregnant during the study time frame * currently receiving or planned to receive dialysis during the study time frame - current use of systemic steroids for any condition * a known allergy to medical grade adhesives, * use of any CGM device in the past 6 months * history of a diagnosed eating disorder * current use of a second-generation antipsychotic at the time of consent (aripiprazole, asenapine, brexpiprazole, cariprazine, clozapine, iloperidone, lurasidone, olanzapine, paliperidone, quetiapine, risperidone, ziprasidone) * subjects lacking capacity to provide informed consent
Where it's running
-
USF Health Department of Family Medicine - Morsani Center for Advanced Health Care
Tampa, Florida, United States Recruiting -
USF Health Department of Family Medicine - University Partnership Center
Tampa, Florida, United States Recruiting
Study contacts
- Principal investigator: Kevin Cowart, PharmD, MPH — University of South Florida
- Study coordinator: Kevin Cowart, PharmD, MPH
- Email: kcowart2@usf.edu
- Phone: 813-974-5562
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Lifestyle Metabotype Study B: Understanding Personalized Glucose Responses
This study tests how lifestyle, metabolism, and brain energy use relate to each person’s blood sugar response after meals, across people with and without prediabetes or type 2 diabetes.
-
Lifestyle Metabotype Study: How Daily Habits Shape Blood Sugar
This observational study tests whether personal lifestyle and biological factors can predict how a person’s blood sugar responds after meals.
-
Hourly stair-climbing snacks to improve blood sugar and heart health in adults with prediabetes
This study tests whether short stair-climbing bursts every hour can improve blood sugar and vascular health in adults with prediabetes.
-
Smart probiotic and nutraceutical approach for cardiometabolic health in older adults
This trial tests whether a probiotic-containing nutraceutical strategy can improve metabolic health and blood pressure in adults over 65 with prediabetes or cardiovascular disease.
-
Family-based diabetes prevention for parents and kids
A family-focused program tests whether a 12-week lifestyle plan can help parents at risk for diabetes lose weight and improve healthy habits for themselves and their children aged 12–17.
-
Cardiorespiratory and muscular fitness in children with obesity and autism
This study tests whether cardiorespiratory fitness and handgrip strength differ between children with obesity who have autism and those who do not, and how these fitness measures relate to body size, composition, and cardiometabolic health.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.